Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending March 30, 2006. The report serves as a notification of transactions involving Directors, Persons Discharging Managerial Responsibility, or Connected Persons regarding Ordinary Shares of the company.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is strictly a regulatory disclosure of share transactions and does not contain financial performance data.
Material Changes
The filing details specific transfers of Ordinary Shares from the GlaxoSmithKline Employee Trust ("GSK Trust") to participants in the SmithKline Beecham Employee Share Option Plan 1991:
- March 24, 2006: Transfer of 28,565 shares.
- March 27, 2006: Transfer of 19,036 shares.
- March 28, 2006: Transfer of 34,420 shares.
Additionally, the company corrected a previous notification regarding a transaction on March 1, 2006. The actual number of shares transferred was 12,043, correcting a prior report of 14,143 shares.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. It notes that the GSK Trust is a discretionary trust for current and former employees, and three directors (Dr J-P Garnier, Dr T Yamada, and Mr J S Heslop) hold interests in the trust shares similarly to other employees.
Investor Verification Points
- Verify the correction of the March 1, 2006 share transfer count (12,043 vs. 14,143).
- Confirm the total volume of shares transferred to the 1991 Employee Share Option Plan during late March 2006.
- Note that this filing does not reflect operational or financial performance for the period.